VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes

Filter search : Quote Research All


Reports for search string : CAGR

Visaka Industries: Buy for an upside potential of 28% over a period of 18 months
We initiate coverage on Visaka as a BUY with a price objective of Rs 986, representing a potential upside of 28% over a period of 18 months. We have arrived at the price target by ...
Ventura Securities, 22 Jan 2018
Muthoot Capital Services: Revenue grows 50.35% in Q3FY18 ; Overweight
Revenues of the company were Rs. 1051.40 mn in Q3 FY18 as against Rs. 699.30 mn in Q3 FYl7, an increase of 50.35%. Net Sales and PAT of the company are expected to grow at a CAGR of 27% and 34% 2016 t...
Firstcall India Equity, 22 Jan 2018
NCL Industries: Buy for a target implying an upside of 108% over 24 months
We expect the stock of NCLI to get re-rated sharply given the improved visibility on revenue growth, profitability, future expansion plans and EBITDA/ton of cement division nearing Rs 1000/ton. Buy.
Ventura Securities, 19 Jan 2018
Cyient Q3FY18: Healthy performance; Upside 20%
Rolling over our estimates to FY20E, we maintain our BUY recommendation on the stock with a revised Target Price of Rs700 (from Rs 605 earlier).
Reliance Securities, 19 Jan 2018
Poddar Pigments Q3FY18: PAT to grow at a CAGR of 9% over 2016 to 2019E; Overweight
During 9M FY18, net profit stood at Rs. 146.79 mn as compared to Rs. 151.21 mn in 9M FY17. Operating Profit and PAT of the company are expected to grow at a CAGR of 11% and 9% over 2016 to 2019E, resp...
Firstcall India Equity, 19 Jan 2018
Thirumalai Chemicals Q3FY18: Stellar performance; Overweight
During Q3FY18, the consolidated net profit stood at Rs. 514.60 mn from Rs. 150.90 mn in Q3 FY17, up by 241.02%, and consolidated EBIDTA is Rs. 816.00 mn as against Rs. 412.50 mn in the corresponding p...
Firstcall India Equity, 19 Jan 2018
M M Forgings: Buy at CMP over a period of 9-12 months
Though overseas business remains paramount, domestic sales has been gaining traction in the last few fiscals as its contribution to total revenues has increased from ~27% in FY14 to ~36% in FY17.
CD Equisearch Pvt Ltd, 18 Jan 2018
Hindustan Unilever 3QFY18: Stellar Performance on Lower Base & Demand Recovery; Buy
On the back of lower base effect coupled with increased growth momentum, Hindustan Unilever (HUL) has reported strong set of numbers for 3QFY18. Gross margins improved 290bps YoY to 53.1%
Reliance Securities, 18 Jan 2018
DHP India Q3FY18: Net Profit grows a whopping 178.44%; Overweight
During Q3FY18, Profit before tax increased by 178.44% at Rs. 70.61 mn as compared to Rs. 25.36 mn in Q3 FY17. Net Sales and PAT of the company are expected to grow at a CAGR of 8% and 32% over 2016 to...
Firstcall India Equity, 18 Jan 2018
Jay Bharat Maruti Q3FY18: PAT to grow at a CAGR of 14% over 2016 to 2019E; Overweight
At CMP of Rs. 553.50, the stock P/E ratio is at 20.24 X FY18E and 17.87 X F Y19E respectively. Net Sales and PAT of the company are expected to grow at a CAGR of 11% and 14% over 2016 to 2019E, respec...
Firstcall India Equity, 18 Jan 2018
Eris Lifesciences: Generates consistent free cash flows with no significant debt on the books
With focus on speciality and super-speciality segments (expected to grow at consistent rate) and untapped capacity at hand, the company is expected to maintain its growth trajectory. The company is c...
SPA Securities, 18 Jan 2018
Amber Enterprises India IPO: Subscribe to the issue
The Company plans to reduce its debt (~INR 3700 mn) with the IPO proceeds (~INR 4750 mn) which translates into an EPS of INR 27 for FY19E from INR 12 for FY17 assuming similar utilization levels.
SPA Securities, 17 Jan 2018
Federal Bank Q3FY18: Modest quarter; outlook remains brighter
Federal Bank has delivered a modest performance in 3QFY18. Led by strong growth in net interest income along with lower provision expenses, its PAT grew by 26.4% YoY. NII surged by 20% YoY and 5.7% Qo...
Reliance Securities, 17 Jan 2018
S H Kelkar & Company Q2FY18: Firstcall overweight for medium to long term investment
Consolidated revenue stood at Rs. 2831.20 mn from Rs. 2494.20 mn, when compared with the prior year period, an increase of 13.51%. Consolidated PBT increased by 14.43% to Rs. 416.30 mn in Q3 FY18 from...
Firstcall India Equity, 17 Jan 2018
Genesys International Corporation Q2FY18: Revenue grows by 38.87% YoY; Overweight
Revenue for the 2nd quarter rose by 38.87% to Rs. 293.03 mn from Rs. 211.01 mn, when compared with the prior year period. During the quarter, EBIDTA is Rs. 126.57 mn as against Rs. 84.59 mn in the yea...
Firstcall India Equity, 17 Jan 2018
Amber Enterprises IPO: Subscribe with Long Term View
We like the industry and the backward integrated business model of the company. We believe the investment phase of the company is now coming to end and hence the benefits would stat reflecting on the ...
Nirmal Bang, 17 Jan 2018
Subscribe to Amber Enterprises India IPO
Co being market leader in RAC OEM/ODM industry in India have reputed clientele with strong track record of financial performance.Looking after strong future prospects of co with decen...
Hem Securities, 16 Jan 2018
Beekay Steel Q2FY18: Net Profit grows a whopping 139.51%; Overweight
During Q2 FY18, Net profit jumps to Rs. 388.57 mn from Rs. 162.23 mn in Q2 FY17, an increase of 139.51%. At CMP of Rs. 520.00, the stock P/E ratio is at 14.60 X FY18E and 11.82 X FY19 respectively. We...
Firstcall India Equity, 16 Jan 2018
Insecticides (India) Q2FY18: PAT to grow at a CAGR of 32% over 2017 to 2019E; Overweight
At CMP of Rs. 831.95, the stock P/E ratio is at 22.69 x F Y18E and 19.15 X F Y19E respectively. Net Sales and PAT of the company are expected to grow at a CAGR of 10% and 32% over 2017 to 2019E, respe...
Firstcall India Equity, 16 Jan 2018
MAS Financial Services: An efficient player in high growth product segment; Buy
MEL and SME accounts for 83%+ of the totalAUM vs 64% in FY13. The company has impeccable track record of 39% PAT CAGR overFY12-17 with consistent ROA (on AUM) of 2%+.
Motilal Oswal, 12 Jan 2018
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: